In July 2020, Agilent Technologies recently unveiled pioneering solutions for the surging Global Cannabidiol (CBD) Testing Market, addressing challenges in potency and pesticide/mycotoxin assessments for cannabis and hemp. Launching the Agilent eMethods tool and two kits—Cannabis and Hemp Potency, and Cannabis Pesticide and Mycotoxin—the brand offers a swift setup with step-by-step instructions and consumables for comprehensive analysis. This innovative approach streamlines lab operations, aiding compliance with varying regulations. Monty Benefiel and Angelica Riemann, Agilent VPs, emphasized these solutions' role in establishing efficient testing procedures, enhancing productivity, and minimizing risks
